Just over a month ago, at the BIO virtual conference, Pfizer Commercial Director John Young said the company was not thinking of a return on investment for its rapidly developing COVID-19 vaccine. Instead, he said, “finding medical solutions to this crisis” was a Pfizer priority. But now that the company …
Read More »
In the context of several pharmaceutical companies that reported sales declines in the second quarter due to COVID-19, AstraZeneca represents a rare exception, thanks to the strong performance of its cancer drugs. In the second quarter, AZ’s oncology portfolio generated $ 2.61 billion, a 24% year-over-year increase with constant exchange …
Read More »
Russia is aiming to approve a COVID-19 vaccine in a matter of weeks, although the country has yet to release data on its vaccine tests, CNN reported Tuesday. Russian authorities told the outlet they hope to obtain approval for a vaccine developed by the Moscow-based Gamaleya Institute on or before …
Read More »